Abhishek Gaur, MBA

Director
Syneos Health, India

Poster(s):

• (82) Impact of Specialty Referral Timing on Treatment Start and Cost Outcomes in Amyotrophic lateral sclerosis (ALS): A Real-World Claims Analysis
  Wednesday, October 29, 2025

• (161) Benchmarking GLP-1 Patient Access Across Products Using a Comprehensive Score Derived from Real-World Pharmacy Claims
  Wednesday, October 29, 2025

• (277) Impact of Manufacturer Coupon Use on Product Switching in Major Depressive Disorder (MDD) Treatment
  Wednesday, October 29, 2025

• (312) Leveraging Causal Analysis to Identify Trastuzumab Biosimilar Adoption Drivers and Patient Outcomes: A Real-World Claims Data Analysis
  Wednesday, October 29, 2025

• (326) Real-world treatment patterns, costs, and burden of illness in advanced or unresectable cutaneous melanoma following discontinuation of frontline PD-1 inhibitor therapy: A claims database analysis
  Wednesday, October 29, 2025